Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 4980251, 8 pages
http://dx.doi.org/10.1155/2016/4980251
Clinical Study

The Correlation of Serum Myeloid-Related Protein-8/14 and Eosinophil Cationic Protein in Patients with Coronary Artery Disease

The Affiliated Hospital of Zhejiang Traditional Chinese Medicine University, Hangzhou 310006, China

Received 25 August 2015; Revised 22 October 2015; Accepted 6 December 2015

Academic Editor: Koichiro Wada

Copyright © 2016 Guo-lian Xia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Mizuno, R. F. Jacob, and R. P. Mason, “Inflammation and the development of atherosclerosis,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 5, pp. 351–358, 2011. View at Google Scholar
  2. P. Oktayoglu, M. Bozkurt, N. Mete, M. Caglayan, S. Em, and K. Nas, “Elevated serum levels of calprotectin (myeloid-related protein 8/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life,” The Journal of Investigative Medicine, vol. 62, no. 6, pp. 880–884, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Croce, H. Gao, Y. Wang et al., “Myeloid-related protein-8/14 is critical for the biological response to vascular injury,” Circulation, vol. 120, no. 5, pp. 427–436, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Tagaya, M. Kondo, S. Kirishi, M. Kawagoe, N. Kubota, and J. Tamaoki, “Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma,” Journal of Asthma, vol. 52, no. 5, pp. 512–518, 2015. View at Publisher · View at Google Scholar
  5. C. E. Ramarokoto, A. O. Kildemoes, B. S. Randrianasolo et al., “Eosinophil granule proteins ECP and EPX as markers for a potential early-stage inflammatory lesion in Female Genital Schistosomiasis (FGS),” PLoS Neglected Tropical Diseases, vol. 8, no. 7, Article ID e2974, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Ghaffari, S. A. Sede, N. Rashtchizadeh, G. Mohammadzadeh, and S. Majidi, “Association of CRP gene polymorphism with CRP levels and coronary artery disease in type 2 diabetes in Ahvaz, southwest of Iran,” BioImpacts, vol. 4, no. 3, pp. 133–139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. G. Gensini, “A more meaningful scoring system for determining the severity of coronary heart disease,” The American Journal of Cardiology, vol. 51, no. 3, p. 606, 1983. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Franchi, P. Marino, G. G. Biondi-Zoccai, G. Luca, C. Vassanelli, and P. Agostoni, “Transradial versus transfemoral approach for percutaneous coronary procedures,” Current Cardiology Reports, vol. 11, no. 5, pp. 391–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. W. G. Austen, J. E. Edwards, R. L. Frye et al., “A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association,” Circulation, vol. 51, pp. 7–38, 1975. View at Google Scholar
  10. M. Ikemoto, T. Tanaka, Y. Takai, H. Murayama, K. Tanaka, and M. Fujita, “New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection,” Clinical Chemistry, vol. 49, no. 4, pp. 594–600, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Healy, M. D. Pickard, A. D. Pradhan et al., “Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events,” Circulation, vol. 113, no. 19, pp. 2278–2284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Inaba, K. Hokamura, K. Nakano et al., “Upregulation of S100 calcium-binding protein A9 is required for induction of smooth muscle cell proliferation by a periodontal pathogen,” FEBS Letters, vol. 583, no. 1, pp. 128–134, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Santilli, L. Paloscia, R. Liani et al., “Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment,” Journal of the American Heart Association, vol. 3, no. 4, 2014. View at Publisher · View at Google Scholar
  14. T. Vogl, K. Tenbrock, S. Ludwig et al., “Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock,” Nature Medicine, vol. 13, no. 9, pp. 1042–1049, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. McCormick, F. Rahimi, Y. V. Bobryshev et al., “S100A8 and S100A9 in human arterial wall: implications for atherogenesis,” The Journal of Biological Chemistry, vol. 280, no. 50, pp. 41521–41529, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. A. Altwegg, M. Neidhart, M. Hersberger et al., “Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes,” European Heart Journal, vol. 28, no. 8, pp. 941–948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Thelin, O. Melander, and B. Ohlin, “Early rule-out of acute coronary syndrome using undetectable levels of high sensitivity troponin T,” European Heart Journal: Acute Cardiovascular Care, vol. 4, no. 5, pp. 403–409, 2015. View at Publisher · View at Google Scholar
  18. M. G. Ionita, A. Vink, I. E. Dijke et al., “High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 8, pp. 1220–1227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Katashima, T. Naruko, F. Terasaki et al., “Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients,” Circulation Journal, vol. 74, no. 4, pp. 741–748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Croce, “S100A8/A9 complex: more than just a biomarker of cardiovascular risk?” Circulation Journal, vol. 74, no. 4, pp. 626–627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. K.-C. Chang, C.-W. Lo, T.-C. Fan et al., “TNF-α mediates eosinophil cationic protein-induced apoptosis in BEAS-2B cells,” BMC Cell Biology, vol. 11, no. 1, p. 6, 2010. View at Publisher · View at Google Scholar
  22. G. Niccoli, D. Schiavino, F. Belloni et al., “Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents,” European Heart Journal, vol. 30, no. 11, pp. 1340–1347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Niccolia, G. Ferrantea, N. Cosentinoa et al., “Eosinophil cationic protein: a new biomarker of coronary atherosclerosis,” Atherosclerosis, vol. 211, no. 2, pp. 606–611, 2010. View at Publisher · View at Google Scholar
  24. E. Emanuele, C. Falcone, A. D'Angelo et al., “Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease,” Atherosclerosis, vol. 186, no. 1, pp. 140–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. C. R. Kelly, G. Weisz, A. Maehara et al., “Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study),” American Journal of Cardiology, vol. 114, no. 3, pp. 376–383, 2014. View at Google Scholar